BioPharma Drive: Drug Pricing

DECEMBER 9, 2023

Study results disclosed at the American Society of Hematology meeting Saturday suggested potential for cell therapy in lupus and pointed out drug trial limitations.

Disease 128

Disease Drug Trials Therapies Trials 128

Drugs.com

DECEMBER 9, 2023

SATURDAY, Dec. 9, 2023 -- It has likely happened to everyone at some point: You are poised to go to sleep, but instead a "digital distraction" keeps you up hours later than you had planned."Bedtime procrastination is a common problem, as people.

104

104

BioPharma Drive: Drug Pricing

DECEMBER 9, 2023

Follow-up data continue to show Lyfgenia can address the pain crises people with sickle cell experience, although Bluebird’s therapy will be compared to Vertex and CRISPR Therapeutics’ Casgevy, which was also approved Friday.

Therapies 76

Therapies 76

Drug Patent Watch

DECEMBER 9, 2023

This chart shows the pharmaceutical companies with the most concentrate dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most concentrate dosed drugs… The post Which pharmaceutical companies have the most concentrate dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials